BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase

BrightSpring Health Services (NASDAQ:BTSG) announced a secondary offering of 15,000,000 existing common shares by certain stockholders, including an affiliate of KKR and management.

Rhea-AI Summary

BrightSpring Health Services (NASDAQ:BTSG) announced a secondary offering of 15,000,000 existing common shares by certain stockholders, including an affiliate of KKR and management. No new shares are issued and BrightSpring receives no proceeds.

The company authorized a concurrent share repurchase of up to the lesser of 10% of offered shares or $60 million, purchasing from the underwriter at the same price paid to selling stockholders. Goldman Sachs is sole book-running manager.

Positive

• Authorized share repurchase up to $60 million concurrent with offering
• Repurchase limited to up to 10% of secondary shares sold
• Company pays no underwriting fees on repurchased shares

Negative

• Selling stockholders offering 15,000,000 existing shares of common stock
• BrightSpring will receive no proceeds from the secondary offering
• Share repurchase may use up to $60 million of company cash

Argus Jun 4 session

-5.72% close to close Open Argus

Details

News Market Reaction – BTSG

In the Jun 4 session, BTSG declined 5.72%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.7% in the session following this news. A negative reaction despite the concurrent...

Analysis

The stock moved -5.7% in the session following this news. A negative reaction despite the concurrent repurchase fits prior patterns, where similar buyback/secondary announcements averaged about -2.24% over 24 hours. The new 15,000,000-share offering again increases tradable supply from existing holders, which can pressure prices even when the company is not issuing new shares. Investors have also weighed these events against the stock’s strong run from its 52-week low and elevated levels versus the 200-day MA.

Key Figures

Secondary shares offered: 15,000,000 shares Repurchase cap (value): $60.0 million Repurchase cap (percentage): 10% of shares sold +5 more

Secondary shares offered

15,000,000 shares

Aggregate common stock in current secondary offering by selling stockholders

Repurchase cap (value)

$60.0 million

Maximum aggregate purchase price for concurrent share repurchase

Repurchase cap (percentage)

10% of shares sold

Upper limit of shares repurchased relative to secondary size

Current price

$59.15

Pre-news trading level on 2026-06-03

52-week high

$62.11

Upper end of 52-week trading range before this news

52-week low

$19.01

Lower end of 52-week trading range before this news

Offering-related price move (historical)

-2.24%

Average 24h move for past buybacks,offering news

Publication date

2026-06-03

Announcement date for new secondary and repurchase authorization

Previous Buybacks,offering Reports

2 past events · Latest: Mar 02

Same Type 2 events

1. Mar 02

   Secondary pricing & buyback

   24h Move

   -2.2%

   Pricing 20M-share secondary and concurrent capped share repurchase.

2. Mar 02

   Secondary announcement

   24h Move

   -2.2%

   Announcement of 20M-share secondary and planned concurrent repurchase.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

secondary offering, share repurchase, underwriter, book-running manager, +2 more

6 terms

secondary offering financial

"intend to offer for sale in a secondary offering an aggregate of 15,000,000 shares"

A secondary offering is when a company sells new shares of its stock to the public after its initial sale. This allows existing shareholders or the company itself to raise additional money. For investors, it can impact the stock’s price by increasing the total number of shares available, which may influence the stock’s value and how the market perceives the company’s financial health.

View in glossary

share repurchase financial

"the concurrent purchase from the underwriter, out of the 15,000,000 shares"

A share repurchase is when a company uses cash to buy its own shares from the market, reducing the number of shares available to outside investors. Like a homeowner buying back rooms in a shared house to increase their own stake, repurchases can raise earnings per share and often signal management thinks the stock is undervalued, but they also use up cash that could have gone to dividends, investments, or debt reduction — all important considerations for investors.

underwriter financial

"the concurrent purchase from the underwriter, out of the 15,000,000 shares"

An underwriter is a financial firm that evaluates, guarantees and helps sell a new security offering—such as a stock or bond—by buying the issue from the issuer and reselling it to investors or organizing the sale. Think of them as a bridge or safety net: they take on the risk, set the price, handle marketing and paperwork, and their work determines how much money a company can raise and how smoothly the offering reaches the market.

View in glossary

book-running manager financial

"Goldman Sachs & Co. LLC is acting as the sole book-running manager"

A book-running manager is the lead organizer responsible for coordinating a large financial sale, such as issuing new stocks or bonds. They oversee preparing all necessary documents, setting the sale’s price, and finding buyers, much like a concert promoter arranging a major event. Their role matters to investors because they help ensure the offering is successfully sold at the best possible terms.

prospectus regulatory

"A shelf registration statement (including a prospectus) on Form S-3"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

prospectus supplement regulatory

"The offering of these securities will be made only by means of a preliminary prospectus supplement"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the “Selling Stockholders”), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, intend to offer for sale in a secondary offering an aggregate of 15,000,000 shares of common stock of BrightSpring. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering.

In addition, the Company has authorized, subject to the completion of the offering, the concurrent purchase from the underwriter, out of the 15,000,000 shares of common stock being sold as part of the secondary public offering, a number of shares having an aggregate purchase price of up to the lesser of 10% of the shares sold in the offering or $60.0 million at a price per share equal to the price per share to be paid by the underwriter to the Selling Stockholders. The underwriter will not receive any underwriting fees for the shares being repurchased by the Company. The closing of the share repurchase is conditioned on, and expected to occur simultaneously with, the closing of the offering. The offering is not conditioned upon the completion of the share repurchase.

Goldman Sachs & Co. LLC is acting as the sole book-running manager for the proposed offering.

A shelf registration statement (including a prospectus) on Form S-3 relating to these securities was filed with the Securities and Exchange Commission on June 10, 2025 and became automatically effective upon filing. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of these securities will be made only by means of a preliminary prospectus supplement and accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus for the offering may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing Prospectus-ny@ny.email.gs.com.

Forward Looking Statements

The statements contained in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on BrightSpring’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These expectations, beliefs, and projections are expressed in good faith and BrightSpring believes there is a reasonable basis for them. However, there can be no assurance that these expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional, or local economic, business, competitive, market, regulatory, and other factors, many of which are beyond BrightSpring’s control. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in BrightSpring’s filings with the SEC under caption “Risk Factors,” including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and subsequent other filings BrightSpring makes with the SEC from time to time. Any forward-looking statement in this press release speaks only as of the date of this release. BrightSpring undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

Contacts

Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
ir@brightspringhealth.com

or

Media Contact:
Leigh White
leigh.white@brightspringhealth.com
502.630.7412

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BrightSpring (NASDAQ:BTSG) announce about its June 2026 secondary offering?

BrightSpring announced a secondary public offering of 15,000,000 existing common shares by certain stockholders. According to BrightSpring, no new shares are issued, and the company itself will not receive any of the proceeds from this offering.

How large is the BrightSpring (BTSG) secondary offering and who is selling?

The secondary offering covers 15,000,000 BrightSpring common shares sold by certain existing stockholders. According to BrightSpring, the sellers include an affiliate of Kohlberg Kravis Roberts and certain members of management, while the company is not selling any shares.

What is the size and structure of BrightSpring's concurrent share repurchase in June 2026?

BrightSpring authorized a concurrent share repurchase tied to the secondary offering. According to BrightSpring, it may buy shares totaling up to the lesser of 10% of the offered shares or $60 million, at the same price paid by the underwriter to selling stockholders.

Will BrightSpring (BTSG) pay underwriting fees on the concurrent share repurchase?

BrightSpring stated that it will not pay underwriting fees on the shares it repurchases. According to BrightSpring, these repurchased shares will come from the underwriter as part of the secondary offering, reducing transaction costs on the buyback portion.

Who is managing the BrightSpring (BTSG) June 2026 secondary stock offering?

Goldman Sachs & Co. is acting as the sole book-running manager for the BrightSpring secondary offering. According to BrightSpring, the sale will be made under an effective Form S-3 shelf registration using a preliminary prospectus supplement and accompanying prospectus.

Does BrightSpring's June 2026 secondary offering include a primary share issuance or raise capital for BTSG?

The June 2026 transaction does not raise primary capital for BrightSpring. According to BrightSpring, only existing stockholders are selling shares, the company receives no offering proceeds, and capital deployment instead occurs through the authorized concurrent share repurchase program.